Hummingbird Bioscience
Kevin Fongching Chau, PhD, currently works at Hummingbird Bioscience as a Disease Area Strategy and Target Biology professional. Prior to this, they have gained extensive experience in various research and development roles in the biotech industry, including positions at Biotech Connection Singapore, Entrepreneur First, Nanyang Technological University, Boston Children's Hospital, Biogen, and more. Their educational background includes a Ph.D. from Harvard University and a Bachelor of Science from the University of Wisconsin-Madison.
This person is not in any offices
Hummingbird Bioscience
1 followers
Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.